Abstract
Purpose of Review
Lung cancer is the leading cause of cancer mortality, and in the ageing population, the elderly account for the majority of cases. Treatment options are continually expanding, and when patients of a good performance status are suspected of having lung cancer, a systematic assessment to confirm the diagnosis and establish a stage is necessary. Endobronchial ultrasound (EBUS) is a key tool, and we explore the utility of this in the elderly population.
Recent Findings
Over the past 20 years, EBUS has been shown to be an invaluable tool, comparable and exceeding in some cases the traditional mediastinoscopy. Studies show that EBUS can be performed with low complication rates and under moderate sedation, while in the elderly population, data demonstrates that it is safe and effective.
Summary
The elderly population shares the highest burden of thoracic malignancy, and building evidence suggests that EBUS is an effective diagnostic and staging tool, which can be safely performed in this patient group.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. https://doi.org/10.3322/caac.21262.
•• Royal College of Physicians CQID, January 2018. National Lung Cancer Audit annual report 2017 (for the audit period 2016) Royal College of Physicians, Care Quality Improvement Department. 2018. This annual national UK audit gives the most accurate representation of newly diagnosed lung cancers in a population.
Tas F, Ciftci R, Kilic L, Karabulut S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013;6(5):1507–13. https://doi.org/10.3892/ol.2013.1566.
West HJ, Jin JOJAMA. Oncology patient page. Performance status in patients with cancer. JAMA Oncol. 2015;1(7):998. https://doi.org/10.1001/jamaoncol.2015.3113.
Statistics OoN. Cancer registration statistics England. Office of National statistics UK 2016.
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER cancer statistics review (CSR) 1975-2012: lung and bronchus. Natl Cancer Inst. 2014;
•• Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(12):1675–84. https://doi.org/10.1097/JTO.0000000000000678. Updated information on the TNM 8 th edition staging information for nodal disease.
•• Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e211S-e50S. doi:https://doi.org/10.1378/chest.12-2355. These American guidelines for staging non-small cell lung cancer are detailed, reviewing the evidence and making varying levels of recommendations based on systematic reviews, e250S.
De leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–98. https://doi.org/10.1093/ejcts/ezu028.
NICE. Lung cancer: diagnosis and management. National Institute for Health and Care Excellence. 2011.
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.
Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980;45(8):2220–4.
Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996;32A(7):1135–41.
Gridelli C, Ardizzoni A, Le Chevalier T, Manegold C, Perrone F, Thatcher N, et al. Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol. 2004;15(3):419–26.
Aggarwal C, Langer CJ. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer. Curr Opin Oncol. 2012;24(2):130–6. https://doi.org/10.1097/CCO.0b013e32834ea6ea.
de Rijke JM, Schouten LJ, ten Velde GP, Wanders SL, Bollen EC, Lalisang RI, et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer. 2004;46(2):233–45. https://doi.org/10.1016/j.lungcan.2004.03.011.
Driessen EJM, Schulkes KJG, Dingemans AC, van Loon JGM, Hamaker ME, Aarts MJ, et al. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer. Lung Cancer. 2018;116:55–61. https://doi.org/10.1016/j.lungcan.2017.12.013.
Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, et al. Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years. Eur J Cardiothorac Surg. 2017;53:980–6. https://doi.org/10.1093/ejcts/ezx437.
Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4(10):1247–53. https://doi.org/10.1097/JTO.0b013e3181ae285d.
Furuta M, Hayakawa K, Katano S, Saito Y, Nakayama Y, Takahashi T, et al. Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol. 1996;26(2):95–8.
• Samuels MA, Kandula S, Koru-Sengul T, Bogart JA, Salama JK, Aridgides PD, et al. Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium. Clin Lung Cancer. 2013;14(4):446–51. https://doi.org/10.1016/j.cllc.2013.03.004. A retrospective study in the elderly population undergoing stereotactic radiotherapy, demonstrating excellent tolerance and response rates.
Stokes WA, Bronsert MR, Meguid RA, Blum MG, Jones BL, Koshy M, et al. Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non-small-cell lung cancer. J Clin Oncol. 2018;36(7):642–51. https://doi.org/10.1200/JCO.2017.75.6536.
Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist. 2004;9(6):633–43. https://doi.org/10.1634/theoncologist.9-6-633.
Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009;361(1):32–9. https://doi.org/10.1056/NEJMoa0900043.
Fielding DI, Kurimoto N. EBUS-TBNA/staging of lung cancer. Clin Chest Med. 2013;34(3):385–94. https://doi.org/10.1016/j.ccm.2013.06.003.
Rintoul RC, Tournoy KG, El Daly H, Carroll NR, Buttery RC, van Kralingen K, et al. EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes—an international multi-centre experience. J Thorac Oncol : Off Publ Int Assoce Stud Lung Cancer. 2009;4(1):44–8. https://doi.org/10.1097/JTO.0b013e3181914357.
Herth FJF, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008;133(4):887–91. https://doi.org/10.1378/chest.07-2535.
Vilmann P, Clementsen PF, Colella S, Siemsen M, De Leyn P, Dumonceau JM, et al. Combined endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer. European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). Eur Respir J. 2015;46(1):40–60. https://doi.org/10.1183/09031936.00064515.
Cameron RB, Andaz S, Hoal G, Hua-Feng L, Doyle M, Benfield J. Extended cervical mediastinoscopy (ECM) for biopsy of aortopulmonary window (APW) lymph nodes and an APW index (APWI) useful in patient selection. J Thorac Oncol. 2015;10(9 SUPPL. 2):S336.
AC K, FC D. General aspects of surgical treatment. diagnosis and treatment of lung cancer: an evidence- based guide for the practicing clinician. Philadelphia: WB Saunders; 2001.
Zakkar M, Tan C, Hunt I. Is video mediastinoscopy a safer and more effective procedure than conventional mediastinoscopy? Interact Cardiovasc Thorac Surg. 2012;14(1):81–4. https://doi.org/10.1093/icvts/ivr044.
Sampsonas F, Kakoullis L, Lykouras D, Karkoulias K, Spiropoulos K. EBUS: faster, cheaper and most effective in lung cancer staging. Int J Clin Pract. 2018;72 https://doi.org/10.1111/ijcp.13053.
•• Navani N, Nankivell M, Lawrence DR, Lock S, Makker H, Baldwin DR, et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic randomised controlled trial. Lancet Respir Med. 2015;3(4):282–9. https://doi.org/10.1016/S2213-2600(15)00029-6. This study randomised patients to undergo conventional versus EBUS staging, and demonstrated the power of EBUS in improving the time to diagnosis and decision-making in patients with lung cancer.
Erer OF, Erol S, Anar C, Aydogdu Z, Ozkan SA. Diagnostic yield of EBUS-TBNA for lymphoma and review of the literature. Endosc Ultrasound. 2017;6(5):317–22. https://doi.org/10.4103/2303-9027.180762.
Lin SM, Ni YL, Kuo CH, Lin TY, Wang TY, Chung FT, et al. Endobronchial ultrasound increases the diagnostic yields of polymerase chain reaction and smear for pulmonary tuberculosis. J Thorac Cardiovasc Surg. 2010;139(6):1554–60. https://doi.org/10.1016/j.jtcvs.2010.02.019.
Gupta D, Dadhwal DS, Agarwal R, Gupta N, Bal A, Aggarwal AN. Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest. 2014;146(3):547–56. https://doi.org/10.1378/chest.13-2339.
Verma A, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of central lung parenchymal lesions. Yonsei Med J. 2013;54(3):672–8. https://doi.org/10.3349/ymj.2013.54.3.672.
Nakajima T, Yasufuku K, Shibuya K, Fujisawa T. Endobronchial ultrasound-guided transbronchial needle aspiration for the treatment of central airway stenosis caused by a mediastinal cyst. Eur J Cardiothorac Surg. 2007;32(3):538–40. https://doi.org/10.1016/j.ejcts.2007.06.010.
Safety WAfP. Implementation manual WHO surgical safety check list (first edition). In: Organization WH, editor. First ed. United States of America: WHO publications; 2008.
Domain NEpS. National safety standards for invasive procedures. NHS England. 2015.
Weld LR, Stringer MT, Ebertowski JS, Baumgartner TS, Kasprenski MC, Kelley JC, et al. TeamSTEPPS improves operating room efficiency and patient safety. Am J Med Qual. 2016;31(5):408–14. https://doi.org/10.1177/1062860615583671.
NHS England (2015) Never events list 2015/16. NHS England 2015.
Du Rand IA, Barber PV, Goldring J, Lewis RA, Mandal S, Munavvar M, et al. Summary of the British Thoracic Society guidelines for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax. 2011;66(11):1014–5. https://doi.org/10.1136/thoraxjnl-2011-201052.
• Wahidi MM, Herth F, Yasufuku K, Shepherd RW, Yarmus L, Chawla M, et al. Technical aspects of endobronchial ultrasound-guided transbronchial needle aspiration: CHEST guideline and expert panel report. Chest. 2016;149(3):816–35. https://doi.org/10.1378/chest.15-1216. This series of systematic reviews examines various technical aspects of performing EBUS.
Kristjansson SR, Nesbakken A, Jordhoy MS, Skovlund E, Audisio RA, Johannessen HO, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol. 2010;76(3):208–17. https://doi.org/10.1016/j.critrevonc.2009.11.002.
Yarmus LB, Akulian JA, Gilbert C, Mathai SC, Sathiyamoorthy S, Sahetya S, et al. Comparison of moderate versus deep sedation for endobronchial ultrasound transbronchial needle aspiration. Ann Amer Thorac Soc. 2013;10(2):121–6. https://doi.org/10.1513/AnnalsATS.201209-074OC.
Casal RF, Lazarus DR, Kuhl K, Nogueras-Gonzalez G, Perusich S, Green LK, et al. Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus moderate sedation. Am J Respir Crit Care Med. 2015;191(7):796–803. https://doi.org/10.1164/rccm.201409-1615OC.
Franzen D, Schneiter D, Weder W, Kohler M. Impact of sedation technique on the diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle aspiration. Endosc Ultrasound. 2017;6(4):257–63. https://doi.org/10.4103/2303-9027.190925.
• Ost DE, Ernst A, Lei X, Feller-Kopman D, Eapen GA, Kovitz KL, et al. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE Bronchoscopy Registry. Chest. 2011;140(6):1557–66. https://doi.org/10.1378/chest.10-2914. This is a large, predominantly U.S. registry of interventional pulmonology—with useful information on EBUS results and complications.
Antoniades N, Worsnop C. Topical lidocaine through the bronchoscope reduces cough rate during bronchoscopy. Respirology. 2009;14(6):873–6. https://doi.org/10.1111/j.1440-1843.2009.01587.x.
Kaur H, Dhooria S, Aggarwal AN, Gupta D, Behera D, Agarwal R. A randomized trial of 1% vs 2% lignocaine by the spray-as-you-go technique for topical anesthesia during flexible bronchoscopy. Chest. 2015;148(3):739–45. https://doi.org/10.1378/chest.15-0022.
Webb J. Local anaesthesia for fibreoptic bronchoscopy—where are we now? Respir Med. 1990;84(5):349–50.
Ameer B, Burlingame MB, Harman EM. Systemic absorption of topical lidocaine in elderly and young adults undergoing bronchoscopy. Pharmacotherapy. 1989;9(2):74–81.
Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 2013;68(Suppl 1):i1–i44. https://doi.org/10.1136/thoraxjnl-2013-203618.
Cox B, Durieux ME, Marcus MA. Toxicity of local anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17(1):111–36.
Watts MR, Geraghty R, Moore A, Saunders J, Swift CG. Premedication for bronchoscopy in older patients: a double-blind comparison of two regimens. Respir Med. 2005;99(2):220–6.
(NCEPOD) NCEiPOaD. Elderly patients vulnerable because of excessive doses of sedatives. NCEPOD. 2004.
Naidich DP, Harkin TJ. Airways and lung: correlation of CT with fiberoptic bronchoscopy. Radiology. 1995;197(1):1–12. https://doi.org/10.1148/radiology.197.1.7568805.
Lee HS, Lee GK, Lee HS, Kim MS, Lee JM, Kim HY, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest. 2008;134(2):368–74. https://doi.org/10.1378/chest.07-2105.
Yarmus L, Akulian J, Gilbert C, Feller-Kopman D, Lee HJ, Zarogoulidis P, et al. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Ann Am Thorac Soc. 2013;10(6):636–43. https://doi.org/10.1513/AnnalsATS.201305-130OC.
Wang Memoli JS, El-Bayoumi E, Pastis NJ, Tanner NT, Gomez M, Huggins JT, et al. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011;140(6):1550–6. https://doi.org/10.1378/chest.11-0252.
Trisolini R, Cancellieri A, Tinelli C, de Biase D, Valentini I, Casadei G, et al. Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping. Chest. 2015;148(6):1430–7. https://doi.org/10.1378/chest.15-0583.
Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Impact of rapid on-site cytological evaluation (ROSE) on the diagnostic yield of transbronchial needle aspiration during mediastinal lymph node sampling: systematic review and meta-analysis. Chest. 2017;153:929–38. https://doi.org/10.1016/j.chest.2017.11.004.
Ofiara LM, Navasakulpong A, Beaudoin S, Gonzalez AV. Optimizing tissue sampling for the diagnosis, subtyping, and molecular analysis of lung cancer. Front Oncol. 2014;4:253. https://doi.org/10.3389/fonc.2014.00253.
Nguyen S, Ferland N, Beaudoin S, Martel S, Simon M, Laberge F, et al. Influence of trainee involvement on procedural characteristics for linear endobronchial ultrasound. Thorac Cancer. 2017;8(5):517–22. https://doi.org/10.1111/1759-7714.12481.
Eapen GA, Shah AM, Lei X, Jimenez CA, Morice RC, Yarmus L, et al. Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE registry. Chest. 2013;143(4):1044–53. https://doi.org/10.1378/chest.12-0350.
Evison M, Crosbie PAJ, Martin J, Bishop P, Doran H, Joseph L, et al. EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes. J Thorac Oncol : Off Publ Int Assoc Stud Lung Cancer. 2014;9(3):370–6. https://doi.org/10.1097/JTO.0000000000000085.
Kayawake H, Chen-Yoshikawa TF, Oda H, Motoyama H, Hamaji M, Menju T, et al. Complications of endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Surg. 2017;104(5):e363–e5. https://doi.org/10.1016/j.athoracsur.2017.06.015.
Kuchuk M, Guber A, Koslow M, Matveitchouk A, Shitrit D. Endoscopic ultrasound examination in elderly lung patients: our experience at meir medical center. Harefuah. 2015;154(8):481–542.
Okachi S, Imai N, Imaizumi K, Hase T, Shindo Y, Sakamoto K, et al. Endobronchial ultrasound transbronchial needle aspiration in older people. Geriatr Gerontol Int. 2013;13(4):986–92. https://doi.org/10.1111/ggi.12043.
Holty JE, Kuschner WG, Gould MK. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005;60(11):949–55. https://doi.org/10.1136/thx.2005.041525.
Jaffe TA, Raiff D, Ho LM, Kim CY. Management of anticoagulant and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol. 2015;205(2):421–8. https://doi.org/10.2214/AJR.14.13342.
Pathak V, Allender JE, Grant MW. Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures. Eur Respir Rev. 2017;26(145):170020. https://doi.org/10.1183/16000617.0020-2017.
Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006;129(3):734–7. https://doi.org/10.1378/chest.129.3.734.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Lindsey Taylor, Kate Webster and Cyrus Daneshvar declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Pulmonology and Respiratory Care
Rights and permissions
About this article
Cite this article
Taylor, L., Webster, K. & Daneshvar, C. Endobronchial Ultrasound (EBUS) for Staging Lung Cancer in the Elderly Population—Specific Procedural and Medication Issues. Curr Geri Rep 7, 190–199 (2018). https://doi.org/10.1007/s13670-018-0251-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13670-018-0251-3